Author: News Room

If you purchased or acquired securities in Outlook between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OTLK. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and reminds investors of the January 2, 2024 deadline to seek the role…

Read More

If you purchased or acquired securities in Farfetch between March 9, 2023 and August 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FTCH. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and reminds investors of the December 19, 2023 deadline to seek the role of…

Read More

If you purchased or acquired securities in DLocal stock or options between May 2, 2022 and May 25, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DLO. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and reminds investors of the December 5, 2023 deadline to seek…

Read More

If you purchased or acquired securities in Beauty Health between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) and reminds investors of the January 16, 2024 deadline to…

Read More

If you purchased or acquired (i) GigaCloud Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); and/or (ii) GigaCloud securities between August 18, 2022 and September 27, 2023, and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/GCT. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading…

Read More

If you purchased or acquired securities in Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ILMN. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) and reminds investors of the January 9, 2024 deadline to seek the role of…

Read More

If you purchased or acquired securities in SC Health Corporation (“SC Health”) (NYSE: SCPE; NYSE: SCPE.WS; NYSE: SCPE.U) and Rockley Photonics Holdings Limited (“Rockley”) (NYSE: RKLY; NYSE: RKLY.WS) securities between March 19, 2021 and January 23, 2023, inclusive (the “Class Period”) and purchasers directly in the March 2021 private investment in public equity of Rockley shares (the “PIPE Offering”) conducted in connection with the merger of SC Health and Rockley (the “Merger”) and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for…

Read More

If you purchased or acquired securities in Capstone between June 14, 2021 and September 22, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CGRNQ. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Capstone Green Energy Corporation (“Capstone” or the “Company”) (NASDAQ: CGRN, OTC: CGRNQ) and reminds investors of the December 12, 2023 deadline to…

Read More

If you purchased or acquired securities in Barclays between July 22, 2019 and October 12, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/BCS. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the…

Read More

November 26, 2023 BlueSeal MR Mobile’s unique magnet technology advances patient outcomes and access to care with high quality diagnostic imaging and enhanced workflows Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today showcases the world’s first mobile MRI system with helium-free operations at #RSNA23. BlueSeal MR Mobile [1], the industry’s first and only 1.5T fully sealed magnet, delivers patient-centric MRI services where and whenever needed. Unlike other mobile MRI scanners, the BlueSeal MR Mobile is more agile and lightweight so it can be located in more convenient places for…

Read More